Janux Therapeutics (JANX) Receivables (2020 - 2026)

Janux Therapeutics (JANX) posted quarterly Receivables of $42.5 million for Q1 2026, up 560.59% quarter-over-quarter from $6.4 million in Q4 2025.

Janux Therapeutics (JANX) Receivables (2020 - 2026) Analysis & Trends

Janux Therapeutics (JANX) has reported Receivables for 7 consecutive years, with $42.5 million the latest figure, recorded in Q1 2026.

In Q1 2026, Receivables changed N/A year-over-year to $42.5 million; the TTM figure through Mar 2026 stood at $42.5 million (changed N/A YoY), while the FY2025 annual figure was $6.4 million, changed N/A from the prior year.
Receivables climbed to $42.5 million in Q1 2026 per JANX's latest filing, from $6.4 million in the prior quarter.
Across five years, Receivables topped out at $42.5 million in Q1 2026 and bottomed at $500000.0 in Q3 2022.
Historically, Receivables has averaged $9.8 million across 5 years, with a median of $4.4 million in 2024.
On a YoY basis, Receivables climbed as much as 484.8% in 2024 and fell as far as 484.8% in 2024.
Janux Therapeutics' Receivables stood at $500000.0 in 2022, then jumped by 332.2% to $2.2 million in 2023, then jumped by 457.89% to $12.1 million in 2024, then plunged by 46.68% to $6.4 million in 2025, then surged by 560.59% to $42.5 million in 2026.
Business Quant data shows JANX's Receivables at $42.5 million in Q1 2026, $6.4 million in Q4 2025, and $12.1 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	2.13 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	6.57 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	1.93 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	1.06 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	1.84 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	912.74 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	215.33 Mn
10	Janux Therapeutics	984.58 Mn	984.58 Mn	-	6.33 Mn

Download Data